Evidence map›Paper›PMID 42227164›Full record

ArticleAmerican journal of hematology2026

JAKPOT Prediction Rule for Erythrocytosis: External Validation and Cost-Effectiveness Analysis.

Barbara D Lam, Satoko Ito, Justine Ryu, Kevin O'Sullivan, Kunal Potnis, Roosevelt Lu, Aram Bidikian, Ding Quan Ng, Rishabh Singh, Aaron Deter and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Barbara D LamDivision of Hematology and Oncology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-5585-3823
Satoko ItoSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
Justine RyuSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
Kevin O'SullivanDivision of Hematology and Oncology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Kunal PotnisYale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0009-0000-8092-8295
Roosevelt LuDivision of Hematology and Oncology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Aram BidikianYale School of Medicine, New Haven, Connecticut, USA.
Ding Quan NgSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
Rishabh SinghDepartment of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Aaron DeterDepartment of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Christina CarfagniniDepartment of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Simon BecharaDepartment of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Manasa KandulaDepartment of Internal Medicine, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
Nhan DoMassachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
Nate FillmoreMassachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
Jason A FreedDivision of Hematology and Oncology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Rushad PatellDivision of Hematology and Oncology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Jennifer LaMassachusetts Veterans Epidemiology Research and Information Center, Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA.
George GoshuaSection of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0002-1624-4427

Funding

Targeted, adaptive and time-variant strategies for bleed prevention across the lifespan for persons with hemophilia AK01HL175220 · NHLBI · YALE UNIVERSITY · PI George Goshua · 2024 to 2026
$520k
NHLBI NIH HHS K01 HL175220
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cost‐benefit analysisdecision analysiserythrocytosisJAK2myeloproliferative neoplasmpolycythemia vera

Identifiers

PMID42227164
PMCPMC13428362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.